跳至主要内容
临床试验/NCT01188538
NCT01188538已完成4 期

Anti P. Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel in the Treatment of Subjects With Acne Vulgaris

Galderma R&D1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Galderma R&D
入组人数
40
试验地点
1
主要终点
Change From Baseline (Log10 Cfu/cm²) in Count of Follicular P. Acnes

研究概览

简要总结

The purpose of this study is to evaluate the antibacterial activity of Epiduo® Gel (Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel) on P. acnes compared to that of Benzoyl Peroxide 2.5% Gel.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with facial acne,
  • Subjects with high levels of P. acnes counts on the forehead

排除标准

  • Female Subjects who are pregnant, nursing or planning a pregnancy during the study,
  • Subjects with acne conglobata, acne fulminans, secondary acne
  • Subjects with known or suspected allergy to one of the test product

研究组 & 干预措施

Epiduo gel

Experimental
  • Dose or Concentration:Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel.
  • Mode and Frequency of Administration:Topical to the face, once daily application in the evening.
  • Duration of Treatment:12 weeks

干预措施: Epiduo gel (Drug)

BPO gel

Active Comparator
  • Dose or Concentration:Adapalene 0% / Benzoyl Peroxide 2.5% Gel.
  • Mode and Frequency of Administration:Topical to the face, once daily application in the evening.
  • Duration of Treatment:12 weeks

干预措施: BPO (Drug)

结局指标

主要结局

Change From Baseline (Log10 Cfu/cm²) in Count of Follicular P. Acnes

时间窗: Week 12

Quantitative bacterial examinations were performed on the subjects' face during the study. These samplings were performed using a method to quantify the follicular microbiological flora of the skin (at Baseline and Week 12 visits).This method consists of a technique allowing the extraction of the outermost layer of epidermis from hair follicle on the cheek and to culture the samplings in order to have the number of P. acnes. Outcome measure = Change from baseline (Log10 cfu/cm²) in count of Follicular P. acnes at end of the study.

次要结局

  • Percent Change (%) in Inflammatory Lesion Counts(Week 12)

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验